199 related articles for article (PubMed ID: 16273360)
1. Clinical significance of estrogen receptor beta in breast cancer.
Saji S; Hirose M; Toi M
Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():21-6. PubMed ID: 16273360
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of the expression of estrogen receptors alpha and beta for endocrine therapy of breast cancer.
Iwase H; Zhang Z; Omoto Y; Sugiura H; Yamashita H; Toyama T; Iwata H; Kobayashi S
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S34-8. PubMed ID: 12819932
[TBL] [Abstract][Full Text] [Related]
4. Ligand-induced regulation of ERalpha and ERbeta is indicative of human breast cancer cell proliferation.
Power KA; Thompson LU
Breast Cancer Res Treat; 2003 Oct; 81(3):209-21. PubMed ID: 14620916
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma.
Gruvberger-Saal SK; Bendahl PO; Saal LH; Laakso M; Hegardt C; Edén P; Peterson C; Malmström P; Isola J; Borg A; Fernö M
Clin Cancer Res; 2007 Apr; 13(7):1987-94. PubMed ID: 17404078
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation inhibitor, procainamide, may decrease the tamoxifen resistance by inducing overexpression of the estrogen receptor beta in breast cancer patients.
Altundag O; Altundag K; Gunduz M
Med Hypotheses; 2004; 63(4):684-7. PubMed ID: 15325017
[TBL] [Abstract][Full Text] [Related]
7. [Estrogen receptor Beta isoforms -- functions and clinical relevance in breast cancer].
Mitter D; Ortmann O; Treeck O
Zentralbl Gynakol; 2005 Aug; 127(4):228-34. PubMed ID: 16037904
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor beta in breast cancer--diagnostic and therapeutic implications.
Hartman J; Ström A; Gustafsson JA
Steroids; 2009 Aug; 74(8):635-41. PubMed ID: 19463683
[TBL] [Abstract][Full Text] [Related]
9. Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer.
Borgquist S; Holm C; Stendahl M; Anagnostaki L; Landberg G; Jirström K
J Clin Pathol; 2008 Feb; 61(2):197-203. PubMed ID: 18223096
[TBL] [Abstract][Full Text] [Related]
10. Genistein in the presence of 17beta-estradiol inhibits proliferation of ERbeta breast cancer cells.
Rajah TT; Du N; Drews N; Cohn R
Pharmacology; 2009; 84(2):68-73. PubMed ID: 19556829
[TBL] [Abstract][Full Text] [Related]
11. Expression of estrogen receptor beta wild-type and its variant ERbetacx/beta2 is correlated with better prognosis in breast cancer.
Sugiura H; Toyama T; Hara Y; Zhang Z; Kobayashi S; Fujii Y; Iwase H; Yamashita H
Jpn J Clin Oncol; 2007 Nov; 37(11):820-8. PubMed ID: 17932113
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
Zhao C; Matthews J; Tujague M; Wan J; Ström A; Toresson G; Lam EW; Cheng G; Gustafsson JA; Dahlman-Wright K
Cancer Res; 2007 Apr; 67(8):3955-62. PubMed ID: 17440111
[TBL] [Abstract][Full Text] [Related]
13. Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome.
Frasor J; Chang EC; Komm B; Lin CY; Vega VB; Liu ET; Miller LD; Smeds J; Bergh J; Katzenellenbogen BS
Cancer Res; 2006 Jul; 66(14):7334-40. PubMed ID: 16849584
[TBL] [Abstract][Full Text] [Related]
14. The changes of estrogen receptor-beta variants expression in breast carcinogenesis: Decrease of estrogen receptor-beta2 expression is the key event in breast cancer development.
Park BW; Kim KS; Heo MK; Yang WI; Kim SI; Kim JH; Kim GE; Lee KS
J Surg Oncol; 2006 May; 93(6):504-10. PubMed ID: 16615154
[TBL] [Abstract][Full Text] [Related]
15. Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits.
McCarty MF
Med Hypotheses; 2006; 66(6):1093-114. PubMed ID: 16513288
[TBL] [Abstract][Full Text] [Related]
16. Association of oestrogen receptor beta 2 (ER beta 2/ER beta cx) with outcome of adjuvant endocrine treatment for primary breast cancer--a retrospective study.
Vinayagam R; Sibson DR; Holcombe C; Aachi V; Davies MP
BMC Cancer; 2007 Jul; 7():131. PubMed ID: 17640362
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer.
Lin CY; Ström A; Li Kong S; Kietz S; Thomsen JS; Tee JB; Vega VB; Miller LD; Smeds J; Bergh J; Gustafsson JA; Liu ET
Breast Cancer Res; 2007; 9(2):R25. PubMed ID: 17428314
[TBL] [Abstract][Full Text] [Related]
18. The role of estrogen receptor beta (ERbeta) in malignant diseases--a new potential target for antiproliferative drugs in prevention and treatment of cancer.
Warner M; Gustafsson JA
Biochem Biophys Res Commun; 2010 May; 396(1):63-6. PubMed ID: 20494112
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells.
Hodges-Gallagher L; Valentine CD; El Bader S; Kushner PJ
Breast Cancer Res Treat; 2008 May; 109(2):241-50. PubMed ID: 17638070
[TBL] [Abstract][Full Text] [Related]
20. Expression of ERalpha and ERbeta in lobular carcinoma in situ.
Middleton LP; Perkins GH; Tucker SL; Sahin AA; Singletary SE
Histopathology; 2007 Jun; 50(7):875-80. PubMed ID: 17543077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
